UNSPSC 51334306: Zuclopenthixol

This classification denotes an antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47ISU063SG. European Medicines Agency schedules Zuclopenthixol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00195MIG. Zuclopenthixol generally arises in the molecular formula C22H25CLN2OS.

UNSPSC 51334306 Zuclopenthixol is a Commodity code that nominally designates a specific antipsychotic pharmaceutical, but recent state and local procurement activity under this code does not align with that narrow scope. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023—seeks to procure naloxone and drug deactivation systems for community health initiatives, not zuclopenthixol. This mismatch suggests either a tagging error in the county's procurement system or a broader mis-assignment of the code to cover opioid-reversal and harm-reduction products beyond the code's nominal pharmaceutical designation. The scope involves annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to Seminole County Community Health Building in Sanford, Florida, on a fixed-fee basis with an initial two-year term and optional one-year renewal. Vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify authorization, and specified insurance coverage; the procurement is potentially funded through FEMA and carries adherence to federal environmental regulations.

The code shows minimal recent activity in state and local procurement. Geographic spread is limited to Florida, with only Seminole County represented in the current opportunity block. The issuing body is a single county health procurement office rather than a mix of state departments, municipalities, school districts, or other jurisdictions typical of active UNSPSC codes. The mismatch between the code's pharmaceutical name and the actual goods being solicited—opioid antagonists and drug disposal systems—signals that this code may not be the appropriate tracking vehicle for state and local activity in this commodity family, or that the opportunity was misclassified at the point of posting.